Saved in:
| Main Authors: | Luana Miyahira Makita, Rafael de Freitas de Kleimmann, Rafael Reis de Oliveira, Henrique Alexsander Ferreira Neves, Angela Maria Sandini Corso, Vinícius Salles Alves, Giovana Schlichta Adriano Kojima, Aishwarya Koppanatham, Pedro André Kowacs, Elcio Juliato Piovesan |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14921 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
by: Shuu‐Jiun Wang, et al.
Published: (2024)
by: Shuu‐Jiun Wang, et al.
Published: (2024)
Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
by: Gabriel Paiva da Silva Lima, et al.
Published: (2025)
by: Gabriel Paiva da Silva Lima, et al.
Published: (2025)
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
by: David W. Dodick, et al.
Published: (2025)
by: David W. Dodick, et al.
Published: (2025)
Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
by: Gabriel Camargo de Oliveira, et al.
Published: (2026)
by: Gabriel Camargo de Oliveira, et al.
Published: (2026)
Substance use in a Dutch migraine cohort compared with the general population
by: Thomas C. van den Hoek, et al.
Published: (2024)
by: Thomas C. van den Hoek, et al.
Published: (2024)
Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
by: Graham A. McLeod, et al.
Published: (2025)
by: Graham A. McLeod, et al.
Published: (2025)
Long‐term evolution of white and gray matter structural properties in migraine
by: Álvaro Planchuelo‐Gómez, et al.
Published: (2025)
by: Álvaro Planchuelo‐Gómez, et al.
Published: (2025)
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)
by: Rikki Mangrum, et al.
Published: (2024)
The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
by: Yunus Emre Meydanal, et al.
Published: (2025)
by: Yunus Emre Meydanal, et al.
Published: (2025)
Evaluating associations of migraine‐related vertigo
by: Nazia Karsan, et al.
Published: (2025)
by: Nazia Karsan, et al.
Published: (2025)
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine
by: Anna de Dios, et al.
Published: (2024)
by: Anna de Dios, et al.
Published: (2024)
Afterimage duration differs for migraine with or without aura
by: Florian Rimmele, et al.
Published: (2025)
by: Florian Rimmele, et al.
Published: (2025)
Mechanisms for mindfulness in migraine: Does catastrophizing matter?
by: Rebecca Erwin Wells, et al.
Published: (2024)
by: Rebecca Erwin Wells, et al.
Published: (2024)
Useful considerations for treating migraine in patients with autism
by: Sinifunanya E. Nwaobi
Published: (2026)
by: Sinifunanya E. Nwaobi
Published: (2026)
No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
by: Inga Zalia Tummoszeit, et al.
Published: (2024)
by: Inga Zalia Tummoszeit, et al.
Published: (2024)
Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
by: Chia‐Chun Chiang, et al.
Published: (2024)
by: Chia‐Chun Chiang, et al.
Published: (2024)
Counting the cost: How migraine shapes lives and economies
by: Risako Shirane, et al.
Published: (2025)
by: Risako Shirane, et al.
Published: (2025)
Cardiovascular risk and triptan usage among patients with migraine
by: Ido Peles, et al.
Published: (2025)
by: Ido Peles, et al.
Published: (2025)
Depression and anxiety are not associated with migraine outcomes in children and adolescents
by: Amy A. Gelfand
Published: (2024)
by: Amy A. Gelfand
Published: (2024)
Cognitive and emotional mechanisms underlying migraine quality of life
by: Shiri Shinan‐Altman, et al.
Published: (2026)
by: Shiri Shinan‐Altman, et al.
Published: (2026)
Integrating gepants into clinical practice for the acute treatment of migraine
by: Richard B. Lipton, et al.
Published: (2026)
by: Richard B. Lipton, et al.
Published: (2026)
A retrospective analysis of the use of candesartan for migraine prevention in adolescents
by: Irene Patniyot, et al.
Published: (2024)
by: Irene Patniyot, et al.
Published: (2024)
Chronotype in migraine and tension‐type headache: A population study
by: Da Eun Jung, et al.
Published: (2026)
by: Da Eun Jung, et al.
Published: (2026)
Magnetoencephalography studies in migraine and headache disorders: A systematic review
by: Raghavan Gopalakrishnan, et al.
Published: (2024)
by: Raghavan Gopalakrishnan, et al.
Published: (2024)
Causal associations between genetically predicted placental weight and migraine
by: Chung‐Chih Liao, et al.
Published: (2025)
by: Chung‐Chih Liao, et al.
Published: (2025)
Time to reconsider the association between migraine and white matter hyperintensities?
by: Anders Hougaard
Published: (2025)
by: Anders Hougaard
Published: (2025)
Investigating the causal and genetic relationship between migraine and Parkinson's disease
by: Ming‐Gang Deng, et al.
Published: (2024)
by: Ming‐Gang Deng, et al.
Published: (2024)
Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
by: Bilal Ahmed Rizvi, et al.
Published: (2024)
by: Bilal Ahmed Rizvi, et al.
Published: (2024)
Unmet treatment needs in migraine: Results of the OVERCOME (US) study
by: Susan Hutchinson, et al.
Published: (2026)
by: Susan Hutchinson, et al.
Published: (2026)
The role of stress in the comorbidity of migraine and other chronic primary pain
by: Shi‐Jie Zhao, et al.
Published: (2025)
by: Shi‐Jie Zhao, et al.
Published: (2025)
Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
by: Antonio Munafò, et al.
Published: (2026)
by: Antonio Munafò, et al.
Published: (2026)
Prevalence and burden of migraine in the United States: A systematic review
by: Fred Cohen, et al.
Published: (2024)
by: Fred Cohen, et al.
Published: (2024)
The “central vein sign” to differentiate multiple sclerosis from migraine
by: Giulia Silvestri, et al.
Published: (2025)
by: Giulia Silvestri, et al.
Published: (2025)
Microneedles for the treatment of migraine and orofacial pain: A narrative review
by: Baicheng Cao, et al.
Published: (2026)
by: Baicheng Cao, et al.
Published: (2026)
The association between posttraumatic stress disorder and migraine: A systematic review
by: Lucie Nitsche, et al.
Published: (2026)
by: Lucie Nitsche, et al.
Published: (2026)
Effectiveness and acceptability of oral migraine preventives: A prospective, observational study
by: Hedda S. Riise, et al.
Published: (2026)
by: Hedda S. Riise, et al.
Published: (2026)
Evidence for increased background neural noise in migraine with aura: Hyperactive but not hyperresponsive
by: Louise O'Hare, et al.
Published: (2025)
by: Louise O'Hare, et al.
Published: (2025)
Delayed urticaria during treatment with anti‐ CGRP monoclonal antibodies in migraine
by: Christoph T. Berger, et al.
Published: (2026)
by: Christoph T. Berger, et al.
Published: (2026)
Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage
by: Iyas Daghlas, et al.
Published: (2024)
by: Iyas Daghlas, et al.
Published: (2024)
Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
by: Jonathan R. Treadwell, et al.
Published: (2025)
by: Jonathan R. Treadwell, et al.
Published: (2025)
Similar Items
-
Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
by: Shuu‐Jiun Wang, et al.
Published: (2024) -
Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
by: Gabriel Paiva da Silva Lima, et al.
Published: (2025) -
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
by: David W. Dodick, et al.
Published: (2025) -
Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
by: Gabriel Camargo de Oliveira, et al.
Published: (2026) -
Substance use in a Dutch migraine cohort compared with the general population
by: Thomas C. van den Hoek, et al.
Published: (2024)